Atlas Trials

Memorial Sloan Kettering Cancer Center

1,945 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Memorial Sloan Kettering Cancer Center

RecordFirmDate
Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01508312)Memorial Sloan Kettering Cancer Center2012-01-05
Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study (NCT01517945)Memorial Sloan Kettering Cancer Center2012-01-01
Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma (NCT01491698)Memorial Sloan Kettering Cancer Center2011-12-01
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma (NCT01492673)Memorial Sloan Kettering Cancer Center2011-12-01
International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center (NCT01504152)Memorial Sloan Kettering Cancer Center2011-12-01
Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer (NCT01502592)Memorial Sloan Kettering Cancer Center2011-12-01
Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma (NCT01484093)Memorial Sloan Kettering Cancer Center2011-11-29
Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations (NCT01482923)Memorial Sloan Kettering Cancer Center2011-11-22
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer (NCT01471483)Memorial Sloan Kettering Cancer Center2011-11-08
Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging (NCT01474577)Memorial Sloan Kettering Cancer Center2011-11-08
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging (NCT01473693)Memorial Sloan Kettering Cancer Center2011-11-01
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients (NCT01473680)Memorial Sloan Kettering Cancer Center2011-11-01
Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma (NCT01474564)Memorial Sloan Kettering Cancer Center2011-11-01
Patient Factors Impacting Adherence to Oral Chemotherapy (NCT01487343)Memorial Sloan Kettering Cancer Center2011-11-01
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging (NCT01482741)Memorial Sloan Kettering Cancer Center2011-11-01
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases (NCT01470105)Memorial Sloan Kettering Cancer Center2011-11-01
Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients (NCT01466946)Memorial Sloan Kettering Cancer Center2011-11-01
Communication Skills Intervention to Promote Transition Into Survivorship (NCT01483664)Memorial Sloan Kettering Cancer Center2011-11-01
Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation (NCT01474551)Memorial Sloan Kettering Cancer Center2011-11-01
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance (NCT01463670)Memorial Sloan Kettering Cancer Center2011-10-28
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma (NCT01456104)Memorial Sloan Kettering Cancer Center2011-10-17
Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls (NCT01453660)Memorial Sloan Kettering Cancer Center2011-10-11
Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys (NCT01458509)Memorial Sloan Kettering Cancer Center2011-10-11
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) (NCT01443078)Memorial Sloan Kettering Cancer Center2011-10-01
BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) (NCT01453595)Memorial Sloan Kettering Cancer Center2011-10-01
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer (NCT01442051)Memorial Sloan Kettering Cancer Center2011-09-23
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant (NCT01437709)Memorial Sloan Kettering Cancer Center2011-09-01
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies (NCT01430390)Memorial Sloan Kettering Cancer Center2011-09-01
Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (NCT01436240)Memorial Sloan Kettering Cancer Center2011-09-01
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases (NCT01423734)Memorial Sloan Kettering Cancer Center2011-08-23
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab (NCT01416974)Memorial Sloan Kettering Cancer Center2011-08-22
Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors (NCT01419834)Memorial Sloan Kettering Cancer Center2011-08-15
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) (NCT01418001)Memorial Sloan Kettering Cancer Center2011-08-01
Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant (NCT01416246)Memorial Sloan Kettering Cancer Center2011-08-01
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma (NCT01392209)Memorial Sloan Kettering Cancer Center2011-07-08
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies (NCT01393509)Memorial Sloan Kettering Cancer Center2011-07-06
Measuring Patient Expectations for Thyroid Surgery (NCT01412762)Memorial Sloan Kettering Cancer Center2011-07-01
Trial of Modifications to Radical Prostatectomy (NCT01407263)Memorial Sloan Kettering Cancer Center2011-07-01
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) (NCT01399918)Memorial Sloan Kettering Cancer Center2011-07-01
Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy (NCT01404949)Memorial Sloan Kettering Cancer Center2011-07-01
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer (NCT01386411)Memorial Sloan Kettering Cancer Center2011-06-28
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis (NCT01383759)Memorial Sloan Kettering Cancer Center2011-06-24
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors (NCT01379287)Memorial Sloan Kettering Cancer Center2011-06-20
Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others (NCT01392222)Memorial Sloan Kettering Cancer Center2011-06-01
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma (NCT01351623)Memorial Sloan Kettering Cancer Center2011-05-09
Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid (NCT01349647)Memorial Sloan Kettering Cancer Center2011-05-01
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma (NCT01356251)Memorial Sloan Kettering Cancer Center2011-05-01
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer (NCT01354951)Memorial Sloan Kettering Cancer Center2011-05-01
A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery (NCT01355926)Memorial Sloan Kettering Cancer Center2011-05-01
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer (NCT01345175)Memorial Sloan Kettering Cancer Center2011-04-26
Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care (NCT01678118)Memorial Sloan Kettering Cancer Center2011-04-01
Trial of Individual Psychosocial Interventions for Cancer Patients (NCT01323309)Memorial Sloan Kettering Cancer Center2011-03-22
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer (NCT01312857)Memorial Sloan Kettering Cancer Center2011-03-07
Telemedicine Evaluation for Stem Cell Transplant Patients (NCT01324427)Memorial Sloan Kettering Cancer Center2011-03-01
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) (NCT01393483)Memorial Sloan Kettering Cancer Center2011-03-01
Quit IT: Development of a Web-based, 3D Coping Skills Game to Increase Self-Efficacy for Maintaining Smoking Abstinence Following Hospitalization (NCT01915836)Memorial Sloan Kettering Cancer Center2011-03-01
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors (NCT01297452)Memorial Sloan Kettering Cancer Center2011-02-15
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors (NCT01294670)Memorial Sloan Kettering Cancer Center2011-02-09
Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus (NCT01300429)Memorial Sloan Kettering Cancer Center2011-02-08
Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI (NCT01297231)Memorial Sloan Kettering Cancer Center2011-02-01
Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity (NCT01323517)Memorial Sloan Kettering Cancer Center2011-02-01
Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer (NCT01276041)Memorial Sloan Kettering Cancer Center2011-01-05
PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study (NCT01266096)Memorial Sloan Kettering Cancer Center2011-01-01
Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer (NCT01273896)Memorial Sloan Kettering Cancer Center2011-01-01
Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program (NCT01275404)Memorial Sloan Kettering Cancer Center2010-12-28
Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma (NCT01268579)Memorial Sloan Kettering Cancer Center2010-12-28
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma (NCT01261728)Memorial Sloan Kettering Cancer Center2010-12-14
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (NCT01262040)Memorial Sloan Kettering Cancer Center2010-12-14
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study (NCT01269593)Memorial Sloan Kettering Cancer Center2010-12-01
Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events (NCT01262222)Memorial Sloan Kettering Cancer Center2010-12-01
Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial Fibrillation (NCT01253590)Memorial Sloan Kettering Cancer Center2010-12-01
RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder (NCT01259063)Memorial Sloan Kettering Cancer Center2010-12-01
Aerobic Training in Metastatic Breast Cancer (NCT01725633)Memorial Sloan Kettering Cancer Center2010-12-01
Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (NCT01186367)Memorial Sloan Kettering Cancer Center2010-11-11
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy (NCT01239251)Memorial Sloan Kettering Cancer Center2010-11-01
RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma (NCT01252251)Memorial Sloan Kettering Cancer Center2010-11-01
Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast (NCT01249157)Memorial Sloan Kettering Cancer Center2010-11-01
Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer (NCT01248962)Memorial Sloan Kettering Cancer Center2010-11-01
Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission (NCT01248273)Memorial Sloan Kettering Cancer Center2010-11-01
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab (NCT01223235)Memorial Sloan Kettering Cancer Center2010-10-01
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy (NCT01223248)Memorial Sloan Kettering Cancer Center2010-10-01
PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma (NCT01209598)Memorial Sloan Kettering Cancer Center2010-09-23
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome (NCT01200355)Memorial Sloan Kettering Cancer Center2010-09-09
Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers (NCT01213004)Memorial Sloan Kettering Cancer Center2010-09-01
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer (NCT01203839)Memorial Sloan Kettering Cancer Center2010-09-01
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma (NCT01183429)Memorial Sloan Kettering Cancer Center2010-08-12
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow (NCT01183897)Memorial Sloan Kettering Cancer Center2010-08-12
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib (NCT01189435)Memorial Sloan Kettering Cancer Center2010-08-01
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life (NCT01181648)Memorial Sloan Kettering Cancer Center2010-08-01
Rehabilitation of Cognitive Changes in Breast Cancer Survivors (NCT01182506)Memorial Sloan Kettering Cancer Center2010-08-01
Lung Inflammation and Lung Metastases From Breast Cancer (NCT01182519)Memorial Sloan Kettering Cancer Center2010-08-01
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies (NCT01182168)Memorial Sloan Kettering Cancer Center2010-08-01
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma (NCT01183884)Memorial Sloan Kettering Cancer Center2010-08-01
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor (NCT01189643)Memorial Sloan Kettering Cancer Center2010-08-01
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) (NCT01183065)Memorial Sloan Kettering Cancer Center2010-08-01
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins (NCT01189877)Memorial Sloan Kettering Cancer Center2010-08-01
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation (NCT01183416)Memorial Sloan Kettering Cancer Center2010-08-01
Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma (NCT01180569)Memorial Sloan Kettering Cancer Center2010-08-01
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites (NCT01188746)Memorial Sloan Kettering Cancer Center2010-08-01
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer (NCT01186705)Memorial Sloan Kettering Cancer Center2010-08-01
← Previous Next →

Track Memorial Sloan Kettering Cancer Center automatically

Every clearance here is in the API, with alerts when new ones post.